Marksans Pharma Financials
NSE: MARKSANS | BSE: 524404
₹311.00
₹-2.75
(-0.88%)
As on 06-Nov-2026 12:44IST
Market cap
₹13,998 Cr
Revenue (TTM)
₹3,392 Cr
P/E Ratio
25
P/B Ratio
4.2
Div. Yield
0.3 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
3,391.51
|
2,950.94
|
2,622.85
|
2,177.41
|
1,852.14
|
1,490.84
|
|
|
|
|
|
|
Total Income
|
3,490.38
|
3,033.47
|
2,689.17
|
2,227.83
|
1,911.45
|
1,532.69
|
|
|
|
|
|
|
Total Expenditure
|
2,608.02
|
2,350.16
|
2,090.16
|
1,718.83
|
1,512.82
|
1,231.96
|
|
|
|
|
|
|
EBITDA
|
783.49
|
600.78
|
532.68
|
458.58
|
339.32
|
258.88
|
|
|
|
|
|
|
Depreciation
|
105.59
|
98.63
|
83.39
|
74.27
|
51.85
|
44.78
|
|
|
|
|
|
|
EBIT
|
677.90
|
502.15
|
449.30
|
384.31
|
287.47
|
214.10
|
|
|
|
|
|
|
Interest
|
26.08
|
24.13
|
11.66
|
11.20
|
9.13
|
8.45
|
|
|
|
|
|
|
Other Income
|
98.87
|
82.53
|
66.33
|
50.42
|
59.31
|
41.85
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
750.70
|
560.56
|
503.97
|
423.53
|
337.65
|
247.51
|
|
|
|
|
|
|
Provision for Tax
|
185.04
|
140.49
|
121.35
|
108.63
|
72.33
|
60.70
|
|
|
|
|
|
|
Profit after Tax
|
565.65
|
420.06
|
382.62
|
314.90
|
265.32
|
186.81
|
|
|
|
|
|
|
Minority Interest
|
-5.84
|
-2.16
|
-2.04
|
-1.20
|
0.99
|
-2.25
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
559.81
|
417.90
|
380.58
|
313.70
|
266.31
|
184.57
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,332.35
|
3,023.16
|
2,466.91
|
2,065.05
|
1,745.16
|
1,202.27
|
|
|
|
|
|
|
Minority Interest
|
-5.84
|
29.52
|
22.47
|
20.85
|
19.91
|
20.70
|
|
|
|
|
|
|
Non-Current Liabilities
|
392.00
|
268.17
|
272.91
|
205.20
|
84.33
|
57.05
|
|
|
|
|
|
|
Current Liabilities
|
600.33
|
527.09
|
477.34
|
389.85
|
340.99
|
380.08
|
|
|
|
|
|
|
Total Liabilities
|
4,359.62
|
3,855.82
|
3,239.63
|
2,680.95
|
2,190.39
|
1,660.11
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
911.53
|
1,125.20
|
1,035.51
|
818.46
|
515.09
|
435.04
|
|
|
|
|
|
|
Current Assets
|
3,012.28
|
2,722.74
|
2,204.12
|
1,862.49
|
1,675.30
|
1,225.07
|
|
|
|
|
|
|
Total Assets
|
4,359.62
|
3,855.82
|
3,239.63
|
2,680.95
|
2,190.39
|
1,660.11
|
|
|
|
|
|
|
Total Debt*
|
--
|
29.59
|
23.09
|
29.09
|
41.59
|
41.29
|
|
|
|
|
|
|
Net Current Assets
|
2,411.96
|
2,195.65
|
1,726.78
|
1,472.64
|
1,334.31
|
844.98
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
--
|
--
|
--
|
1.45
|
1.45
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
458.13
|
206.66
|
230.41
|
237.41
|
99.26
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-248.27
|
-49.01
|
-140.84
|
-259.21
|
-84.39
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-70.93
|
-65.15
|
-68.73
|
197.83
|
79.51
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
138.93
|
92.51
|
20.84
|
176.03
|
94.38
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
12.35
|
9.22
|
8.40
|
6.92
|
5.88
|
4.51
|
|
|
|
|
|
|
Cash EPS (₹)
|
12.35
|
11.45
|
10.28
|
8.59
|
7.00
|
5.66
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
73.53
|
66.64
|
54.44
|
45.57
|
38.51
|
27.10
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.29
|
0.90
|
0.80
|
0.60
|
0.50
|
0.25
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
10.11
|
4.56
|
5.08
|
5.24
|
2.42
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
7.19
|
1.15
|
1.19
|
3.36
|
1.82
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
21.10
|
22.50
|
22.40
|
22.89
|
23.82
|
|
|
|
|
|
|
ROE (%)
|
17.62
|
15.31
|
16.89
|
16.53
|
18.59
|
18.72
|
|
|
|
|
|
|
ROA (%)
|
14.50
|
11.85
|
12.93
|
12.93
|
13.78
|
12.94
|
|
|
|
|
|
|
EBIT Margin (%)
|
19.99
|
17.02
|
17.13
|
17.65
|
15.52
|
14.36
|
|
|
|
|
|
|
Net Margin (%)
|
16.21
|
13.85
|
14.23
|
14.13
|
13.88
|
12.19
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
17.07
|
16.97
|
17.00
|
15.55
|
14.95
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
24.20
|
12.51
|
20.46
|
17.56
|
24.23
|
8.33
|
|
|
|
|
|
|
EBIT Growth (%)
|
65.91
|
11.76
|
16.91
|
33.69
|
34.27
|
-29.44
|
|
|
|
|
|
|
Net Profit Growth (%)
|
59.18
|
9.79
|
21.51
|
18.68
|
42.02
|
-21.68
|
|
|
|
|
|
|
EPS Growth (%)
|
59.18
|
9.81
|
21.32
|
17.80
|
30.32
|
-21.77
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
22.41
|
19.46
|
18.33
|
57.34
|
25.12
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
25.00
|
17.04
|
26.48
|
21.89
|
11.99
|
10.10
|
|
|
|
|
|
|
Price / Book Value
|
4.20
|
2.36
|
4.08
|
3.33
|
1.83
|
1.68
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.29
|
0.57
|
0.36
|
0.40
|
0.71
|
0.55
|
|
|
|
|
|
|
EV/EBITDA
|
14.69
|
9.02
|
15.68
|
12.23
|
6.32
|
5.18
|
|
|
|
|
|
|
Close Price (₹)
|
322.30
|
156.89
|
222.47
|
151.90
|
70.40
|
45.50
|
|
|
|
|
|
|
High Price (₹)
|
350.95
|
270.70
|
358.70
|
179.30
|
74.42
|
97.60
|
|
|
|
|
|
|
Low Price (₹)
|
155.00
|
155.00
|
130.00
|
69.52
|
38.60
|
43.40
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
13,997.70
|
7,121.50
|
10,075.92
|
6,867.54
|
3,194.38
|
1,864.41
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.01
|
0.01
|
0.01
|
0.02
|
0.04
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.01
|
0.01
|
0.01
|
0.02
|
0.03
|
|
|
|
|
|
|
Current Ratio
|
5.02
|
5.17
|
4.62
|
4.78
|
4.91
|
3.22
|
|
|
|
|
|
|
Quick Ratio
|
3.36
|
3.32
|
2.85
|
3.19
|
3.49
|
2.11
|
|
|
|
|
|
|
Interest Coverage
|
29.79
|
24.24
|
44.22
|
38.80
|
37.99
|
30.31
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
22.33
|
21.84
|
20.59
|
20.81
|
22.51
|
26.48
|
|
|
|
|
|
|
Asset Turnover
|
0.87
|
0.86
|
0.93
|
0.94
|
1.06
|
1.07
|
|
|
|
|
|
|
Receivable days
|
--
|
71.16
|
65.99
|
69.35
|
72.63
|
78.56
|
|
|
|
|
|
|
Inventory Days
|
--
|
109.20
|
97.24
|
87.89
|
81.36
|
97.65
|
|
|
|
|
|
|
Payable days
|
--
|
91.82
|
91.59
|
87.70
|
85.31
|
93.88
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
88.55
|
71.65
|
69.54
|
68.67
|
82.33
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
